Top

Published in:

01-06-2005 | Editorial Commentary

Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena?

Authors: Jörg Dötsch, Kai Nüsken, Michael Schroth, Wolfgang Rascher, Udo Meißner

Published in: Pediatric Nephrology | Issue 6/2005

Abstract

The hypothesis that alterations of serum concentrations of the anorexigenic adipose tissue-derived hormone leptin or the orexigenic peptide ghrelin might help to regain appetite and fight malnutrition in patients with chronic renal failure cannot be confirmed at present. For the future, however, strategies interfering with signal transduction of these peptides in the hypothalamus might be more promising and should be investigated and further developed.

Meier U, Gressner AM (2004) Endocrine regulation of energy metabolism: review of pathobiochemical and clinical chemical aspects of leptin, ghrelin, adiponectin, and resistin. Clin Chem 50:1511

Schwartz MW, Woods SC, Porte D Jr, Seeley RJ, Baskin DG (2000) Central nervous system control of food intake. Nature 404:661PubMed

Halaas JL, Gajiwala KS, Maffei M, Cohen SL, Chait BT, Rabinowitz D, Lallone RL, Burley SK, Friedman JM (1995) Weight-reducing effects of the plasma protein encoded by the obese gene. Science 269:543PubMed

Stephens TW, Basinski M, Bristow PK, Bue-Valleskey JM, Burgett SG, Craft L, Hale J, Hoffmann J, Hsiung HM, Kriauciunas A, et al. (1995) The role of neuropeptide Y in the antiobesity action of the obese gene product. Nature 377:530

Bouret SG, Draper SJ, Simerly RB (2004) Formation of projection pathways from the arcuate nucleus of the hypothalamus to hypothalamic regions implicated in the neural control of feeding behavior in mice. J Neurosci 24:2797

Zhang Y, Proenca R, Maffei M, Barone M, Leopold L, Friedman JM (1994) Positional cloning of the mouse obese gene and its human homologue. Nature 372:425CrossRefPubMed

Montague CT, Farooqi IS, Whitehead JP, Soos MA, Rau H, Wareham NJ, Sewter CP, Digby JE, Mohammed SN, Hurst JA, Cheetham CH, Earley AR, Barnett AH, Prins JB, O’Rahilly S (1997) Congenital leptin deficiency is associated with severe early-onset obesity in humans. Nature 387:903CrossRefPubMed

Clement K, Vaisse C, Lahlou N, Cabrol S, Pelloux V, Cassuto D, Gourmelen M, Dina C, Chambaz J, Lacorte JM, Basdevant A, Bougneres P, Lebouc Y, Froguel P, Guy-Grand B (1998) A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction. Nature 392:398CrossRefPubMed

Heymsfield SB, Greenberg AS, Fujioka K, Dixon RM, Kushner R, Hunt T, Lubina JA, Patane J, Self B, Hunt P, McCamish M (1999) Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial. JAMA 282:1568

10.

Farooqi IS, Jebb SA, Langmack G, Lawrence E, Cheetham CH, Prentice AM, Hughes IA, McCamish MA, O’Rahilly S (1999) Effects of recombinant leptin therapy in a child with congenital leptin deficiency. N Engl J Med 341:879CrossRefPubMed

11.

Oral EA, Simha V, Ruiz E, Andewelt A, Premkumar A, Snell P, Wagner AJ, DePaoli AM, Reitman ML, Taylor SI, Gorden P, Garg A (2002) Leptin-replacement therapy for lipodystrophy. N Engl J Med 346:570CrossRef

12.

Petersen KF, Oral EA, Dufour S, Befroy D, Ariyan C, Yu C, Cline GW, DePaoli AM, Taylor SI, Gorden P, Shulman GI (2002) Leptin reverses insulin resistance and hepatic steatosis in patients with severe lipodystrophy. J Clin Invest 109:1345CrossRefPubMed

13.

Schwartz MW, Peskind E, Raskind M, Boyko EJ, Porte D Jr (1996) Cerebrospinal fluid leptin levels: relationship to plasma levels and to adiposity in humans. Nat Med 2:589PubMed

14.

Dötsch J, Adelmann M, Englaro P, Dötsch A, Hanze J, Blum WF, Kiess W, Rascher W (1997) Relation of leptin and neuropeptide Y in human blood and cerebrospinal fluid. J Neurol Sci 151:185

15.

Krude H, Biebermann H, Luck W, Horn R, Brabant G, Gruters A (1998) Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans. Nat Genet 19:155CrossRefPubMed

16.

Masuzaki H, Paterson J, Shinyama H, Morton NM, Mullins JJ, Seckl JR, Flier JS (2001) A transgenic model of visceral obesity and the metabolic syndrome. Science 294:2166CrossRefPubMed

17.

Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa K (1999) Ghrelin is a growth-hormone-releasing acylated peptide from stomach. Nature 402:656

18.

Monteleone P, DiLieto A, Castaldo E, Maj M (2004) Leptin functioning in eating disorders. CNS Spectr 9:523

19.

Aubert ML, Pierroz DD, Gruaz NM, d’Alleves V, Vuagnat BA, Pralong FP, Blum WF, Sizonenko PC (1998) Metabolic control of sexual function and growth: role of neuropeptide Y and leptin. Mol Cell Endocrinol 140:107

20.

Brichard SM, Delporte ML, Lambert M (2003) Adipocytokines in anorexia nervosa: a review focusing on leptin and adiponectin. Horm Metab Res 35:337CrossRefPubMed

21.

Blum WF (1997) Leptin: the voice of the adipose tissue. Horm Res 48 Suppl 4:2

22.

Frank S, Stallmeyer B, Kampfer H, Kolb N, Pfeilschifter J (2000) Leptin enhances wound re-epithelialization and constitutes a direct function of leptin in skin repair. J Clin Invest 106:501

23.

Date Y, Murakami N, Kojima M, Kuroiwa T, Matsukura S, Kangawa K, Nakazato M (2000) Central effects of a novel acylated peptide, ghrelin, on growth hormone release in rats. Biochem Biophys Res Commun 275:477

24.

Tschop M, Smiley DL, Heiman ML (2000) Ghrelin induces adiposity in rodents. Nature 407:908

25.

Wren AM, Small CJ, Ward HL, Murphy KG, Dakin CL, Taheri S, Kennedy AR, Roberts GH, Morgan DG, Ghatei MA, Bloom SR (2000) The novel hypothalamic peptide ghrelin stimulates food intake and growth hormone secretion. Endocrinology 141:4325CrossRef

26.

Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H, Kangawa K, Matsukura S (2001) A role for ghrelin in the central regulation of feeding. Nature 409:194CrossRefPubMed

27.

Shintani M, Ogawa Y, Ebihara K, Aizawa-Abe M, Miyanaga F, Takaya K, Hayashi T, Inoue G, Hosoda K, Kojima M, Kangawa K, Nakao K (2001) Ghrelin, an endogenous growth hormone secretagogue, is a novel orexigenic peptide that antagonizes leptin action through the activation of hypothalamic neuropeptide Y/Y1 receptor pathway. Diabetes 50:227

28.

Toshinai K, Mondal MS, Nakazato M, Date Y, Murakami N, Kojima M, Kangawa K, Matsukura S (2001) Upregulation of Ghrelin expression in the stomach upon fasting, insulin-induced hypoglycemia, and leptin administration. Biochem Biophys Res Commun 281:1220

29.

Hansen TK, Dall R, Hosoda H, Kojima M, Kangawa K, Christiansen JS, Jorgensen JO (2002) Weight loss increases circulating levels of ghrelin in human obesity. Clin Endocrinol (Oxf) 56:203

30.

Haqq AM, Farooqi IS, O’Rahilly S, Stadler DD, Rosenfeld RG, Pratt KL, LaFranchi SH, Purnell JQ (2003) Serum ghrelin levels are inversely correlated with body mass index, age, and insulin concentrations in normal children and are markedly increased in Prader-Willi syndrome. J Clin Endocrinol Metab 88:174

31.

Guarnieri G, Antonione R, Biolo G (2003) Mechanisms of malnutrition in uremia. J Ren Nutr 13:153

32.

Pupim LB, Ikizler TA (2004) Assessment and monitoring of uremic malnutrition. J Ren Nutr 14:6

33.

Daschner M, Tonshoff B, Blum WF, Englaro P, Wingen AM, Schaefer F, Wuhl E, Rascher W, Mehls O (1998) Inappropriate elevation of serum leptin levels in children with chronic renal failure. European Study Group for Nutritional Treatment of Chronic Renal Failure in Childhood. J Am Soc Nephrol 9:1074

34.

Nüsken KD, Rauh M, Kratzsch J, Stöhr W, Rascher W, Dötsch J (2004) Circulating soluble leptin receptor and free leptin index in children with chronic renal failure. Ped Nephrol 18:C38

35.

Iida M, Murakami T, Yamada M, Sei M, Kuwajima M, Mizuno A, Noma Y, Aono T, Shima K (1996) Hyperleptinemia in chronic renal failure. Horm Metab Res 28:724

36.

Stenvinkel P, Heimburger O, Lonnqvist F (1997) Serum leptin concentrations correlate to plasma insulin concentrations independent of body fat content in chronic renal failure. Nephrol Dial Transplant 12:1321

37.

Merabet E, Dagogo-Jack S, Coyne DW, Klein S, Santiago JV, Hmiel SP, Landt M (1997) Increased plasma leptin concentration in end-stage renal disease. J Clin Endocrinol Metab 82:847

38.

Landt M, Parvin CA, Dagogo-Jack S, Bryant B, Coyne DW (1999) Leptin elimination in hyperleptinaemic peritoneal dialysis patients. Nephrol Dial Transplant 14:732

39.

Zbroch E, Malyszko J, Wolczynski S, Hryszko T, Mysliwiec M (1999) [Concentration of leptin in patients on hemodialysis and peritoneal dialysis]. Pol Arch Med Wewn 101:503

40.

Pecoits-Filho R, Nordfors L, Heimburger O, Lindholm B, Anderstam B, Marchlewska A, Stenvinkel P (2002) Soluble leptin receptors and serum leptin in end-stage renal disease: relationship with inflammation and body composition. Eur J Clin Invest 32:811CrossRef

41.

Havel PJ (2001) Peripheral signals conveying metabolic information to the brain: short-term and long-term regulation of food intake and energy homeostasis. Exp Biol Med (Maywood) 226:963

42.

Yoshimoto A, Mori K, Sugawara A, Mukoyama M, Yahata K, Suganami T, Takaya K, Hosoda H, Kojima M, Kangawa K, Nakao K (2002) Plasma ghrelin and desacyl ghrelin concentrations in renal failure. J Am Soc Nephrol 13:2748

43.

Rodriguez Ayala E, Pecoits-Filho R, Heimburger O, Lindholm B, Nordfors L, Stenvinkel P (2004) Associations between plasma ghrelin levels and body composition in end-stage renal disease: a longitudinal study. Nephrol Dial Transplant 19:421

44.

Nüsken KD, Gröschl M, Rauh M, Stöhr W, Rascher W, Dötsch J (2004) Effect of renal failure and dialysis on circulating ghrelin concentration in children. Nephrol Dial Transplant 19:2156

45.

Kambham N, Markowitz GS, Valeri AM, Lin J, D’Agati VD (2001) Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 59:1498

46.

Bonnet F, Deprele C, Sassolas A, Moulin P, Alamartine E, Berthezene F, Berthoux F (2001) Excessive body weight as a new independent risk factor for clinical and pathological progression in primary IgA nephritis. Am J Kidney Dis 37:720

47.

Meier-Kriesche HU, Arndorfer JA, Kaplan B (2002) The impact of body mass index on renal transplant outcomes: a significant independent risk factor for graft failure and patient death. Transplantation 73:70

48.

Praga M, Hernandez E, Morales E, Campos AP, Valero MA, Martinez MA, Leon M (2001) Clinical features and long-term outcome of obesity-associated focal segmental glomerulosclerosis. Nephrol Dial Transplant 16:1790

49.

Morales E, Valero MA, Leon M, Hernandez E, Praga M (2003) Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 41:319

50.

Knerr I, Horbach T, Plank C, Carbon R, Nüsken KD, Rascher W, Dötsch J (2003) Laparoscopically performed gastric banding in a 13-year-old girl with morbid obesity and end stage renal insufficiency allows lifesaving weight loss and hemodialysis. J Pediatr Endocrinol Metab 16:1179

51.

Wolf G (2003) After all those fat years: renal consequences of obesity. Nephrol Dial Transplant 18:2471

52.

Wolf G, Hamann A, Han DC, Helmchen U, Thaiss F, Ziyadeh FN, Stahl RA (1999) Leptin stimulates proliferation and TGF-beta expression in renal glomerular endothelial cells: potential role in glomerulosclerosis [see comments]. Kidney Int 56:860CrossRefPubMed

53.

Han DC, Isono M, Chen S, Casaretto A, Hong SW, Wolf G, Ziyadeh FN (2001) Leptin stimulates type I collagen production in db/db mesangial cells: glucose uptake and TGF-beta type II receptor expression. Kidney Int 59:1315CrossRefPubMed

54.

Haynes WG, Sivitz WI, Morgan DA, Walsh SA, Mark AL (1997) Sympathetic and cardiorenal actions of leptin. Hypertension 30:619

55.

Schroth M, Gröschl M, Dörr HG, Blum WF, Rascher W, Dötsch J (2001) Renal loss of leptin in patients with nephrotic syndrome. Eur J Endocrinol 145:463

56.

Sarnak MJ, Poindexter A, Wang SR, Beck GJ, Kusek JW, Marcovina SM, Greene T, Levey AS (2002) Serum C-reactive protein and leptin as predictors of kidney disease progression in the Modification of Diet in Renal Disease Study. Kidney Int 62:2208

57.

Dötsch J, Nüsken KD, Schroth M, Rascher W, Meißner U (2004) Endocrine dysregulation in adolescents with chronic renal failure. TxMed 16:19

Title: Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena?
Authors: Jörg Dötsch
Kai Nüsken
Michael Schroth
Wolfgang Rascher
Udo Meißner
Publication date: 01-06-2005
Publisher: Springer-Verlag
Published in: Pediatric Nephrology / Issue 6/2005
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI: https://doi.org/10.1007/s00467-005-1908-7

At a glance: The STEP trials

Springer Medicine

Alterations of leptin and ghrelin serum concentrations in renal disease: simple epiphenomena?

Abstract

At a glance: The STEP trials

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 6/2005

Blood pressure and total peripheral resistance in children with chronic kidney disease

XXIXth Congress of the Spanish Pediatric Nephrology Association, 25 - 28 June 2003, Avila, Spain

Chronic kidney disease and inflammation in pediatric patients: from bench to playground

Beneficial in vitro effect of N-acetyl-cysteine on oxidative stress and apoptosis

A case report and review of hypokalemic paralysis secondary to renal tubular acidosis

How are hypertensive children evaluated and managed? A survey of North American pediatric nephrologists